Capricor Therapeutics, Inc. (CAPR)
NASDAQ·Healthcare·Biotechnology
$6.51
—
Mkt Cap $864.51M
Analyst Ratings
Buy
5
Hold
0
Sell
0
Price Target (16 analysts)
$47.75
Range $13.00 – $62.00
Implied Upside
+633.5%
Consensus $47.75 vs current $6.51
NASDAQ·Healthcare·Biotechnology
$6.51
—
Mkt Cap $864.51M
Buy
5
Hold
0
Sell
0
Price Target (16 analysts)
$47.75
Range $13.00 – $62.00
+633.5%
Consensus $47.75 vs current $6.51